Drugs / Essential Oil
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT03296943 | Jul → Nov 2010 | — | Chulalongkorn University | Completed | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT07490873 | Jan → Jul 2026 | — | University of Baghdad | Completed | No outcome recorded |
| — | NCT05291195 | Feb 2018 → Oct 2021 | chronic apical periodontitis, dental pulp necrosis | University of Belgrade | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Essential Oil | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05291195 ↗ |
| Route | Inhaled | “To inhale the essential oil in an air-conditioned room” NCT03296943 ↗ |